Trial · NCT03740737
Adverse events20
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 20
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Procedural pain | Injury, poisoning and procedural complications | FE 999049 (Follitropin Delta) | 150 | 525 | 156 |
| other | Procedural pain | Injury, poisoning and procedural complications | Placebo | 0 | 53 | 0 |
| other | Morning sickness (Fresh cycle) | Pregnancy, puerperium and perinatal conditions | FE 999049 (Follitropin Delta) | 28 | 525 | 34 |
| other | Morning sickness (Fresh cycle) | Pregnancy, puerperium and perinatal conditions | Placebo | 0 | 53 | 0 |
| other | Pelvic discomfort | Reproductive system and breast disorders | FE 999049 (Follitropin Delta) | 30 | 525 | 33 |
| other | Pelvic discomfort | Reproductive system and breast disorders | Placebo | 2 | 53 | 2 |
| other | Morning Sickness (Cryopreserved cycle) | Pregnancy, puerperium and perinatal conditions | FE 999049 (Follitropin Delta) | 50 | 278 | 60 |
| other | Morning Sickness (Cryopreserved cycle) | Pregnancy, puerperium and perinatal conditions | Placebo | 0 | 53 | 0 |
| other | Haemorrhage in pregnancy | Pregnancy, puerperium and perinatal conditions | FE 999049 (Follitropin Delta) | 31 | 278 | 36 |
| other | Haemorrhage in pregnancy | Pregnancy, puerperium and perinatal conditions | Placebo | 0 | 53 | 0 |
| other | Abortion spontaneous | Pregnancy, puerperium and perinatal conditions | FE 999049 (Follitropin Delta) | 28 | 278 | 30 |
| other | Abortion spontaneous | Pregnancy, puerperium and perinatal conditions | Placebo | 0 | 53 | 0 |
| other | Biochemical pregnancy | Pregnancy, puerperium and perinatal conditions | FE 999049 (Follitropin Delta) | 22 | 278 | 25 |
| other | Biochemical pregnancy | Pregnancy, puerperium and perinatal conditions | Placebo | 0 | 53 | 0 |
| serious | Ovarian hyperstimulation syndrome | Reproductive system and breast disorders | FE 999049 (Follitropin Delta) | 3 | 525 | 3 |
| serious | Ovarian hyperstimulation syndrome | Reproductive system and breast disorders | Placebo | 0 | 53 | 0 |
| serious | Deep vein thrombosis | Vascular disorders | FE 999049 (Follitropin Delta) | 1 | 525 | 1 |
| serious | Deep vein thrombosis | Vascular disorders | Placebo | 0 | 53 | 0 |
| serious | Ectopic pregnancy | Pregnancy, puerperium and perinatal conditions | FE 999049 (Follitropin Delta) | 1 | 278 | 1 |
| serious | Ectopic pregnancy | Pregnancy, puerperium and perinatal conditions | Placebo | 0 | 53 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03740737/events